Pressure BioSciences
Logotype for Pressure BioSciences Inc

Pressure BioSciences (PBIO) investor relations material

Pressure BioSciences has been otc

Pressure BioSciences Status Update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Pressure BioSciences Inc
Status Update summary20 Jun, 2024

Operational updates and relocation

  • Relocation to a new facility with 90% manufacturing labs has improved operational efficiency and reduced costs by consolidating R&D and manufacturing, increasing space by 20% while lowering lease expenses by 20-30%.

  • The move caused significant delays, including late regulatory approvals and lab setup, impacting financial filings and operations, but the company is now fully functional and ready for business.

  • The new facility enables future growth and in-house manufacturing, shifting from a virtual to a manufacturing-focused company.

Financial and compliance status

  • The 2023 10-K annual report was filed late due to relocation delays, with a commitment to avoid future late filings; the Q filing is targeted for June 30.

  • Management acknowledges the inconvenience to stakeholders and is working to restore compliance and maintain it going forward.

Core business and technology focus

  • Pressure Cycling Technology (PCT) and BaroFold remain important, with ongoing sales and service, but focus has shifted to UltraShear technology due to its market potential.

  • UltraShear enables precise, stable nano-emulsions, significantly improving absorption of oil-based actives, as demonstrated in preclinical studies with CBD and THC.

  • UltraShear's applications span pharmaceuticals, nutraceuticals, cosmetics, agrochemicals, and food and beverage, targeting multi-billion dollar markets.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Latest events from Pressure BioSciences
    Pressure BioSciences
    Cover every name on your watchlist this earnings season.
    Automations, AI chat, and live calls across 16,000+ companies.
    Book demo

    AI chat

    Ask anything. Verify everything.

    Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

    Automations

    Zero in on what matters

    Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

    Live audio & transcripts

    Be first

    Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

    Quartr MCP connects your AI environment to 17K+ public companies

    Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
    Included with Quartr Pro at no extra cost.Learn more

    Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

    Jamie Ross

    Investment Manager, GAM Investments

    GAM
    GAM

    Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

    Tom O'Hara

    Investment Director

    Ciena
    Ciena

    Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

    Gregg Lampf

    VP of Investor Relations

    Frequently asked questions

    Pressure BioSciences Inc is a U.S.-based life sciences company that develops high-pressure-based equipment and consumables for biological sample preparation. Its patented platforms are used in biomarker discovery, drug development, and molecular diagnostics. The company serves academic, pharmaceutical, and government research laboratories. It is headquartered in South Easton, Massachusetts, and its shares are listed on the OTCQB.